Methylphenidate, Lisdexamfetamine, Dexamfetamine, Atomoxetine - For Attention Deficit Hyperactivity Disorder in adults aged over 17 years and in children and adolescents aged 6 to 17 years
Guanfacine - For Attention Deficit Hyperactivity Disorder in children and adolescents aged 6 to 17 years
Amisulpride, Aripiprazole, Olanzapine, Quetiapine, Oral Risperidone
This shared prescribing guideline for the second-generation antipsychotic medications listed above has been developed with due consideration to the appropriate NICE Clinical Guidelines (CG) e.g. Bipolar Disorder (CG185), Psychosis and Schizophrenia in Children and Young People (CG155), Psychosis and Schizophrenia in Adults (CG178), Schizophrenia- Aripiprazole (TA213), Bipolar Disorder- Adolescents (TA292).
Please note: Morecambe Bay CCG has now adopted this Shared-care guideline for all areas, including South Cumbria.
To be read in conjunction with the LSCMMG guideline ‘Assessing suitability of strong opioid use’
Assessing suitability for Strong Opioid use Version 1.0
The Lancashire and South Cumbria Self-Care and Access to OTC Medicines – Template policy has been developed for use by care homes in Lancashire and South Cumbria. The policy must be reviewed by each care home for suitability and finalised prior to use.
This policy MUST be read in conjunction with the local or care home medicines policy
- In the management of acute mania or hypomanic episodes
- In the management of episodes of recurrent depressive disorders where treatment with other antidepressants has been unsuccessful
- In the prophylaxis against bipolar affective disorders
- Control of aggressive behaviours of intentional self-harm.
This is a summary document intended for Primary Care, taken from a more comprehensive document ‘Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) in Primary and Secondary Care. This document should be accessed for additional resources such as the Leaflet for Care Home Staff, assessment forms and flow chart for responding to BPSD.
Information contained within this document is largely taken from the PrescQIPP toolkit ‘Reducing Antipsychotics in Dementia and documents available on the Alzheimer’s Society website.
In developing local commissioning policies, the CCG will commission treatments or services which accord with all of the following principles:
A number of treatments which should be considered a LOW PRIORITY are detailed within this policy
Guidance on consensus approaches to managing Palliative Care Symptoms